Pulikottil Okuru Esmy

Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study

Rengaswamy Sankaranarayanan, Priya R. Prabhu, Michael Pawlita et al. · The Lancet Oncology · 2015 · 244 citations · Full text

Effectiveness, safety and acceptability of ‘see and treat’ with cryotherapy by nurses in a cervical screening study in India

Rengaswamy Sankaranarayanan, Rajamanickam Rajkumar, Pulikottil Okuru Esmy et al. · British Journal of Cancer · 2007 · 160 citations · Full text

‘ See, Minimally Invasive Procedure, Gynecology +19

Socio Demographic and Reproductive Risk Factors for Cervical Cancer - a Large Prospective Cohort Study from Rural India

Jissa Vinoda Thulaseedharan, Nea Malila, Matti Hakama et al. · Asian Pacific Journal of Cancer Prevention · 2012 · 66 citations · Full text

Two-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years – updated evidence from Indian follow-up cohort study

Partha Basu, Richard Muwonge, Neerja Bhatla et al. · Papillomavirus Research · 2019 · 32 citations · Full text

Are two doses of human papillomavirus vaccine sufficient for girls aged 15–18 years? Results from a cohort study in India

Neerja Bhatla, Bhagwan M. Nene, Smita Joshi et al. · Papillomavirus Research · 2018 · 26 citations · Full text

Immunology, Are Two, Hpv Infection Outcomes +16